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Headache is a common complaint in the emergency
department (ED). In most of these patients, it is usually
a migraine or tension-type headache. Sometimes, how-
ever, the causes of headache in these patients can be
life-threatening. It is crucial and challenging for ED phy-
sicians to differentiate sinister headaches from benign
ones. Rapid and accurate clinical evaluation is required
to determine the risk of meningitis and the need for a
lumbar puncture in adults with suspected meningitis1.
Cryptococcal meningitis is a potentially fatal infec-
tion caused by a fungus of the Cryptococcus species. It is
an opportunistic infection that is often found in immu-
nocompromised patients, but also sometimes occurs
in immunocompetent patients. For patients with atyp-
ical presentation of headache, chronic central nervous
system (CNS) infection, such as meningitis, should be
ruled out. A lumbar puncture for cerebrospinal fluid (CSF)
analysis is recommended to rule out the rare condition
of meningitis. Lack of neck stiffness or meningeal signs
cannot rule out meningitis2. Clinical decisions regarding
further diagnostic testing and the need for a lumbar
puncture should not rely solely on the presence or ab-
sence of meningeal signs. Better bedside diagnostic tests
are needed1,3.
Case Report
A 64-year-old man with a recent history of hypertension
and a progressive headache with dizziness, nausea, vom-
iting and elevated blood pressure for 2 weeks presented
at our ED. The patient was a known hepatitis B carrier
undergoing regular follow-up. According to his state-
ment, the headache had a new onset with the presence
of dizziness, nausea and vomiting. The characteristics
of the headache were dullness without throbbing. It
was initially located in the right occipital area, and
later spread to the occipital and bilateral temporal areas.
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SUMMARY
Headache is a common complaint in the emergency department (ED). It is crucial and challenging for ED physi-
cians to differentiate life-threatening causes from benign ones. We present a 64-year-old male who attended
our ED suffering from dizziness and elevated blood pressure for the previous 2 days. He had also suffered from
headache during the 2 weeks prior to his presentation at the ED. The patient had a medical history of hyperten-
sion and hepatitis B. After a thorough investigation, including a cerebrospinal fluid (CSF) analysis, his blood and
CSF showed high titers of Cryptococcus. Empirical antifungal antibiotics were given after the CSF analysis. After 
50 days of amphotericin B and fluconazole therapy, he was discharged with oral fluconazole (400 mg/day) and
followed up in the outpatient department. [International Journal of Gerontology 2008; 2(3): 128–132]
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Lying down or turning the head possibly aggravated the
headache. The patient did not report any prodromal
signs, tinnitus or photosensitivity. The headache was not
related to food and was aggravated by sexual behavior.
The patient had also noticed a persistent low-grade
fever (temperature, 37.5–37.8°C) during the previous 2
weeks. He was a city-dweller with no avian or soil con-
tact, and no history of recent travel.
Upon arrival at our ED, he was fully conscious and
his vital signs were as follows: body temperature, 36.4°C;
pulse rate, 53/min; respiratory rate, 18/min; blood pres-
sure, 176/88 mmHg. Physical examination was unre-
markable and neurologic examination showed no
obvious neurologic deficits. The sizes of his pupils were
both 2.5mm with active light reflexes. Laboratory results
revealed leukocytes at 11,000/μL with predominant
neutrophils at 83%, elevated blood sugar of 152 mg/dL
and hypokalemia with a potassium level of 3.3 mEq/L.
Other blood results were unremarkable. A brain com-
puted tomography scan was arranged and revealed low
densities in the bilateral external capsule and lentiform
nucleus, which were consistent with the aging brain
(Figure 1).
A lumbar puncture was performed owing to the
headache and increased intracranial pressure (ICP) signs,
because the neck was supple on physical examination
but lying down worsened the headache. The CSF analy-
sis results were as follows: color, clear and colorless;
appearance, watery; Pandy’s test, trace; red blood cell
count, 415/mm3; white blood cell count, 72/mm3 (all
lymphocytes). The CSF biochemistry results were: CSF
glucose, 33 mg/dL; total protein, 77 mg/dL; lactate
dehydrogenase, 18 IU/L. Serologic examinations were
positive for Cryptococcus antigen in both the serum
and CSF at a titer of 1:1,024. Empirical antifungal
antibiotics with amphotericin B and fluconazole were
given immediately.
After admission to a ward, brain magnetic resonance
imaging was arranged and showed small, old infarcts
in the bilateral putamen, a small, old infarct in the left
centrum semiovale, and small areas of leukoence-
phalopathy in the periventricular and deep white mat-
ter, as well as the basal ganglia (Figure 2). A follow-up CSF
tapping revealed a high titer of Cryptococcus antigen and
a blood culture that developed Cryptococcus neoformans.
The symptoms of headache with elevated blood pres-
sure and increased ICP signs gradually subsided after
treatment with amphotericin B 2 mg/kg/day and oral
fluconazole 400 mg/day for 50 days, and the patient
was discharged from hospital with oral fluconazole
400 mg/day, with regular follow-up in the outpatient
department.
Discussion
Headache is a common complaint. In most patients, it is
usually a migraine or tension-type headache. It is crucial
that physicians are able to differentiate sinister causes
of headache from more benign ones4. Sometimes, 
Figure 1. Brain computed tomography reveals low densities
in the bilateral external capsule and lentiform nucleus, which
were consistent with the aging brain.
Figure 2. Brain magnetic resonance imaging shows small,
old infarcts in the bilateral putamen, a small, old infarct in
the left centrum semiovale, and small areas of leukoen-
cephalopathy in the periventricular and deep white matter,
as well as the basal ganglia.
CNS infection, such as cryptococcal meningitis, should
be considered as a cause of headache. Cryptococcus neo-
formans is found worldwide in association with soil con-
taminated with bird (particularly pigeon) excreta and
usually causes infections in immunosuppressed individ-
uals5. Cryptococcal meningitis is often found in patients
with acquired immunodeficiency syndrome (AIDS) or
those who are immunocompromised for other reasons6.
The present case was unique for several reasons.
Another variety of Cryptococcus species named gatti is
usually found in immunocompetent patients7. In the
present case, the patient had been previously quite
healthy and immunocompetent. He denied any contact
with avian droppings. He also denied any contact with
soil before the illness. The classic clinical presentation
of acute meningitis is a triad of fever, neck stiffness and
an altered mental status. While taking a patient’s history,
clinicians suspecting meningitis will examine for gen-
eral symptoms of infection (such as fever, chills, and
myalgia), as well as symptoms suggesting CNS disorder
(photophobia, headache, nausea and vomiting, focal
neurologic symptoms, or changes in mental status)2. In
the current case, only headache and nausea with some
vomiting were present. Despite a mild fever, it is rare
that ED staff will take meningitis into consideration
without the presence of neck stiffness, unless an alter-
ation of the mental status is detected. For cryptococcal
meningitis, it is difficult to make a diagnosis without a
lumbar puncture examination. This type of atypical
presentation of CNS infection is a real challenge for ED
physicians.
Regarding radiologic examinations, computed
tomography scans may be normal, or only reveal
meningeal enhancement. Magnetic resonance imaging
scans are more sensitive for the detection of multiple
enhanced nodules within the brain parenchyma, me-
ninges, basal ganglia, and midbrain. However, a diag-
nosis of meningitis cannot be made by imaging alone.
Concerning laboratory examinations in apparently im-
munocompetent patients, cultures and antigen tests of
the CSF may sometimes be negative, and a diagnosis of
meningitis is hard to exclude. Detection of cryptococ-
cal polysaccharide antigen in body fluids by rapid and
simple latex agglutination tests or enzyme immunoas-
says has a sensitivity > 90% and is very specific with a
titer of > 1:4. High initial CSF titers (≥ 1:1024) are cor-
related with a high organism burden by quantitative
cultures and represent markers of a poor prognosis5.
Untreated cryptococcal meningitis is uniformly fatal.
Treatment of cryptococcal disease has improved drama-
tically during the last two decades. Before the intro-
duction of polyene antifungal agents, particularly
amphotericin B, disseminated cryptococcal disease,
especially cryptococcal meningitis, was always fatal.
After the establishment of orally bioavailable antifungal
agents, such as flucytosine and azole agents, the treat-
ment of cryptococcal disease entered a new era8,9.
With the development of organ transplantation surgery
involving increased numbers of immunosuppressed
patients and the explosion of the AIDS epidemic around
the world, the incidence of cryptococcal disease has
risen dramatically. Practice guidelines proposed by
Saag et al.8 contained the following suggestions. For
individuals who are unable to tolerate fluconazole,
itraconazole (200–400 mg/day for 6–12 months) is an
acceptable alternative. For patients with more severe
disease, treatment with amphotericin B (0.5–1 mg/
kg/day) may be necessary for 6–10 weeks. For other-
wise healthy hosts with CNS disease, the standard
therapy consists of amphotericin B (0.7–1 mg/kg/day)
plus flucytosine (100 mg/kg/day) for 6–10 weeks. An
alternative to this regimen is amphotericin B
(0.7–1 mg/kg/day) plus 5-flucytosine (100 mg/kg/day)
for 2 weeks, followed by fluconazole (400 mg/day) for a
minimum of 10 weeks. Fluconazole “consolidation”
therapy may be continued for as long as 6–12 months,
depending on the clinical status of the patient8. Other
randomized trials have also suggested combination
antifungal therapies for human immunodeficiency
virus (HIV)-associated cryptococcal meningitis10,11.
Most cases of morbidity and mortality arising from
cryptococcal meningitis are due to elevated ICP and
impaired CSF absorption. Elevated ICP is defined as an
opening pressure of > 200 mmH2O, measured with the
patient in the reclining (lateral decubitus) position.
Several treatment options exist for managing elevated
ICP, including intermittent CSF drainage by sequential
lumbar punctures, insertion of a lumbar drain, or place-
ment of a ventriculoperitoneal shunt8. Fessler et al.12
suggested that placement of lumbar drains and lumbar
peritoneal shunts in patients with HIV and cryptococcal
meningitis is indicated for patients with elevated ICP
that is refractory to more conservative measures. A lit-
erature review recommended that the principal inter-
vention for reducing elevated ICP is percutaneous
lumbar drainage13,14. For patients with an elevated
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baseline opening pressure, lumbar drainage should
remove enough CSF to reduce the opening pressure by
50%. Among HIV-negative patients, the benefit of
steroid therapy is not well established, and such therapy
should not be used. Acetazolamide and mannitol have
not been shown to provide any clear benefit. Aggres-
sive management of elevated ICP is perhaps the most
important factor in reducing the mortality and minimiz-
ing the morbidity of acute cryptococcal meningitis8.
Several prognostic factors had been proposed. Lu
et al.15 showed that only the initial level of conscious-
ness and the CSF antigen titer were strongly associated
with therapeutic failure. Pappas et al.9 identified sev-
eral factors associated with mortality. Specifically, age
≥ 60 years and the presence of significant underlying
disease, especially organ failure syndromes and hema-
tologic malignancy, were consistently associated with
mortality9. Based on a retrospective study of 83 HIV-
negative patients with cryptococcosis, Dromer et al.16
suggested that outcomes were not influenced by the site
of involvement, severity of illness, or administration of
amphotericin B or fluconazole as the initial therapy.
Predictors of death among their patients included age
of > 60 years, underlying neoplastic disease, abnormal
mental status, extrapulmonary disease, and treatment
failure16. Based on data obtained from randomized
clinical trials, the traditional therapy for HIV-negative
patients with cryptococcal meningitis has comprised at
least 6 weeks of therapy with a combination of ampho-
tericin B and flucytosine8,17. As little as 4 weeks of admin-
istration is an effective duration for carefully selected
HIV-negative patients who are not severely immunocom-
promised17. Furthermore, serum cryptococcal antigen
testing for screening is far less reliable for non-HIV-
infected patients than for HIV-positive patients with
cryptococcosis18. Other observations indicate that many
HIV-negative patients with cryptococcosis present with
few or minimal signs and symptoms, and that sero-
logic testing is insensitive for these patients, thereby
creating circumstances that may lead to costly delays
in diagnosis and institution of therapy9.
In summary, for elderly patients with atypical pre-
sentation of headache, chronic CNS infection, such as
meningitis, should be ruled out. The typical triad of
fever, neck stiffness and an altered mental state for
meningitis may not be revealed in elderly patients. A
lumbar puncture for CSF analysis is recommended to
rule out this rare condition.
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